Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease
Identifieur interne : 000227 ( Istex/Corpus ); précédent : 000226; suivant : 000228Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease
Auteurs :Source :
- Vaccine [ 0264-410X ] ; 1995.
English descriptors
- Teeft :
Url:
DOI: 10.1016/0264-410X(95)90208-7
Links to Exploration step
ISTEX:0AFA96123B221A78C7206525DA049667DECD160ELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0AFA96123B221A78C7206525DA049667DECD160E</idno>
<date when="1995" year="1995">1995</date>
<idno type="doi">10.1016/0264-410X(95)90208-7</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-2910BD78-P/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000227</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000227</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease</title>
</analytic>
<monogr></monogr>
<series><title level="j">Vaccine</title>
<title level="j" type="abbrev">JVAC</title>
<idno type="ISSN">0264-410X</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1995">1995</date>
<biblScope unit="volume">13</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="881">881</biblScope>
</imprint>
<idno type="ISSN">0264-410X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0264-410X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Antibodies immunoreactive</term>
<term>Baculovirus</term>
<term>Biological sample</term>
<term>Burgdorferi</term>
<term>Epitope</term>
<term>Fusion protein</term>
<term>Helicase</term>
<term>Helicase region</term>
<term>Herpes virus</term>
<term>Histolytica</term>
<term>Leader protein</term>
<term>Lyme disease</term>
<term>Mengo virus</term>
<term>Passive antibodies</term>
<term>Patent report</term>
<term>Rabies virus</term>
<term>Recombinant</term>
<term>Rous sarcoma virus</term>
<term>Scid mice</term>
<term>Vaccine</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<istex><corpusName>elsevier</corpusName>
<keywords><teeft><json:string>recombinant</json:string>
<json:string>burgdorferi</json:string>
<json:string>histolytica</json:string>
<json:string>helicase</json:string>
<json:string>epitope</json:string>
<json:string>baculovirus</json:string>
<json:string>vaccine</json:string>
<json:string>passive antibodies</json:string>
<json:string>fusion protein</json:string>
<json:string>lyme disease</json:string>
<json:string>rabies virus</json:string>
<json:string>helicase region</json:string>
<json:string>rous sarcoma virus</json:string>
<json:string>leader protein</json:string>
<json:string>herpes virus</json:string>
<json:string>patent report</json:string>
<json:string>scid mice</json:string>
<json:string>mengo virus</json:string>
<json:string>biological sample</json:string>
<json:string>antibodies immunoreactive</json:string>
</teeft>
</keywords>
<arkIstex>ark:/67375/6H6-2910BD78-P</arkIstex>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>Abstract</json:string>
</originalGenre>
<qualityIndicators><score>2.781</score>
<pdfWordCount>769</pdfWordCount>
<pdfCharCount>4728</pdfCharCount>
<pdfVersion>1.2</pdfVersion>
<pdfPageCount>1</pdfPageCount>
<pdfPageSize>583 x 846 pts</pdfPageSize>
<refBibsNative>false</refBibsNative>
<abstractWordCount>1</abstractWordCount>
<abstractCharCount>0</abstractCharCount>
<keywordCount>0</keywordCount>
</qualityIndicators>
<title>Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease</title>
<pii><json:string>0264-410X(95)90208-7</json:string>
</pii>
<genre><json:string>abstract</json:string>
</genre>
<host><title>Vaccine</title>
<language><json:string>unknown</json:string>
</language>
<publicationDate>1995</publicationDate>
<issn><json:string>0264-410X</json:string>
</issn>
<pii><json:string>S0264-410X(00)X0019-9</json:string>
</pii>
<volume>13</volume>
<issue>9</issue>
<pages><first>881</first>
</pages>
<genre><json:string>journal</json:string>
</genre>
</host>
<namedEntities><unitex><date><json:string>1995</json:string>
</date>
<geogName></geogName>
<orgName><json:string>Derwent Publications Ltd</json:string>
</orgName>
<orgName_funder></orgName_funder>
<orgName_provider></orgName_provider>
<persName><json:string>Rex Inst</json:string>
</persName>
<placeName></placeName>
<ref_url></ref_url>
<ref_bibl></ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark><json:string>ark:/67375/6H6-2910BD78-P</json:string>
</ark>
<categories><wos><json:string>1 - science</json:string>
<json:string>2 - medicine, research & experimental</json:string>
<json:string>2 - immunology</json:string>
</wos>
<scienceMetrix><json:string>1 - health sciences</json:string>
<json:string>2 - biomedical research</json:string>
<json:string>3 - virology</json:string>
</scienceMetrix>
<scopus><json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - Infectious Diseases</json:string>
<json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - Public Health, Environmental and Occupational Health</json:string>
<json:string>1 - Health Sciences</json:string>
<json:string>2 - Veterinary</json:string>
<json:string>3 - General Veterinary</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Immunology and Microbiology</json:string>
<json:string>3 - General Immunology and Microbiology</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Molecular Medicine</json:string>
</scopus>
</categories>
<publicationDate>1995</publicationDate>
<copyrightDate>1995</copyrightDate>
<doi><json:string>10.1016/0264-410X(95)90208-7</json:string>
</doi>
<id>0AFA96123B221A78C7206525DA049667DECD160E</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-2910BD78-P/fulltext.pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-2910BD78-P/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/6H6-2910BD78-P/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a">Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease</title>
<title level="a" type="sub">Max Planck Soc; German Cancer Res. Inst. Eur 633 313; 11 January 1995</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher scheme="https://scientific-publisher.data.istex.fr">ELSEVIER</publisher>
<availability><licence><p>elsevier</p>
</licence>
</availability>
<p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M"></p>
<date>1995</date>
</publicationStmt>
<notesStmt><note type="abstract" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-HPN7T1Q2-R">abstract</note>
<note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
<note type="content">Section title: Patent report</note>
</notesStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a">Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease</title>
<title level="a" type="sub">Max Planck Soc; German Cancer Res. Inst. Eur 633 313; 11 January 1995</title>
<idno type="istex">0AFA96123B221A78C7206525DA049667DECD160E</idno>
<idno type="ark">ark:/67375/6H6-2910BD78-P</idno>
<idno type="DOI">10.1016/0264-410X(95)90208-7</idno>
<idno type="PII">0264-410X(95)90208-7</idno>
</analytic>
<monogr><title level="j">Vaccine</title>
<title level="j" type="abbrev">JVAC</title>
<idno type="pISSN">0264-410X</idno>
<idno type="PII">S0264-410X(00)X0019-9</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1995"></date>
<biblScope unit="volume">13</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="881">881</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>1995</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
<revisionDesc><change when="1995">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-2910BD78-P/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Elsevier converted-article found"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType>
<istex:document><converted-article version="4.5.2" docsubtype="abs"><item-info><jid>JVAC</jid>
<aid>95902087</aid>
<ce:pii>0264-410X(95)90208-7</ce:pii>
<ce:doi>10.1016/0264-410X(95)90208-7</ce:doi>
<ce:copyright type="unknown" year="1995"></ce:copyright>
</item-info>
<head><ce:dochead><ce:textfn>Patent report</ce:textfn>
</ce:dochead>
<ce:title>Pathogen strain <ce:italic>Borrelia burgdorferi</ce:italic>
ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease </ce:title>
<ce:subtitle><ce:italic>Max Planck Soc; German Cancer Res. Inst.</ce:italic>
Eur 633 313; 11 January 1995</ce:subtitle>
</head>
</converted-article>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo><title>Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease</title>
<subTitle>Max Planck Soc; German Cancer Res. Inst. Eur 633 313; 11 January 1995</subTitle>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA"><title>Pathogen strain</title>
<subTitle>Max Planck Soc; German Cancer Res. Inst. Eur 633 313; 11 January 1995</subTitle>
</titleInfo>
<typeOfResource>text</typeOfResource>
<genre type="abstract" displayLabel="Abstract" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-HPN7T1Q2-R">abstract</genre>
<originInfo><publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1995</dateIssued>
<copyrightDate encoding="w3cdtf">1995</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<note type="content">Section title: Patent report</note>
<relatedItem type="host"><titleInfo><title>Vaccine</title>
</titleInfo>
<titleInfo type="abbreviated"><title>JVAC</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<originInfo><publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1995</dateIssued>
</originInfo>
<identifier type="ISSN">0264-410X</identifier>
<identifier type="PII">S0264-410X(00)X0019-9</identifier>
<part><date>1995</date>
<detail type="volume"><number>13</number>
<caption>vol.</caption>
</detail>
<detail type="issue"><number>9</number>
<caption>no.</caption>
</detail>
<extent unit="issue-pages"><start>791</start>
<end>882</end>
</extent>
<extent unit="pages"><start>881</start>
</extent>
</part>
</relatedItem>
<identifier type="istex">0AFA96123B221A78C7206525DA049667DECD160E</identifier>
<identifier type="ark">ark:/67375/6H6-2910BD78-P</identifier>
<identifier type="DOI">10.1016/0264-410X(95)90208-7</identifier>
<identifier type="PII">0264-410X(95)90208-7</identifier>
<recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M">elsevier</recordContentSource>
</recordInfo>
</mods>
<json:item><extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-2910BD78-P/record.json</uri>
</json:item>
</metadata>
<author></author>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000227 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000227 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV1 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:0AFA96123B221A78C7206525DA049667DECD160E |texte= Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease }}
This area was generated with Dilib version V0.6.33. |